Allergy & Immunology

Reduced exacerbations, pneumonia hospitalizations seen versus ICS-LABAs in observational study

In retrospective study, 54% mortality rate for those with mucus plugs in 3 or more lung segments

Lung function and symptoms also bettered with biologic in patients with type 2 Inflammation

Also in TTHealthWatch: exercise and infectious disease risk

Helping families move to areas with less pollution or stressors eased symptoms, exacerbations

Also in TTHealthWatch: a peanut allergy patch for young children and orphan drug profits

Choice of alternative route with nasal spray outweighs possible risks, panelists say

No precedent for approval of noninjectable epinephrine for anaphylaxis, noted agency reviewers

Idiopathic CD4 lymphocytopenia not so heterogenous after all

Lower MoCA scores associated with improper inhaler use despite face-to-face training

OTC devices don't work as well as prescription devices -- if they work at all, study shows

After 1 year with extensively hydrolyzed formula, 48% of babies developed immune tolerance

Could preventing RSV infections reduce childhood asthma by 15%?

Twofold higher risk in people with poor sleep patterns and high genetic susceptibility